Filter your search
- $150.00 – $300.00What are virtual reality technologies and how are they being used in healthcare today? What areas of healthcare are seeing the most use of these products? What is the expected market opportunity for companies entering the market for VR equipment? Who are the main players in the VR market and what moves are they making […]February 1, 2011$150.00 – $300.00This report covers the U.S. market for Picture Archiving and Communication Systems (PACS) and provides an overview of imaging systems, EMR and PACS technologies and products. The report describes the industry, its relationship to various healthcare channels, and the trends for the future. The report addresses some of the issues surrounding IT in healthcare and […]February 1, 2011$150.00 – $300.00While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over-the-counter status where possible. In the early part of the last decade there was a decline in Rx-to-OTC switches; […]February 1, 2011$1,995.00 – $3,990.00The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing […]January 1, 2011$150.00 – $300.00Sample preparation and library preparation are important steps in the DNA sequencing process with specialized products and companies. Based on a survey of labs worldwide conducted by Kalorama’s biotech analyst Justin Saeks, this report provides detailed information on the current state of DNA sequencing sample preparation and library preparation for next-generation systems, as well as […]January 1, 2011$2,500.00 – $5,000.00Drug delivery is evolving at a rapid rate with new drug product formulations being discovered frequently. Advanced drug delivery deals with developing solutions for new entities in therapeutic pharmacology such as protein and peptides and other novel compounds targeting drugs to specific disease sites including gene therapy. Treatments for chronic conditions and growth in patient-administered […]December 1, 2010$995.00 – $3,000.00Smartphone and other mobile applications or “apps” are being utilized in many areas of healthcare: education, health management, data management, health information, and other workflow processes. This Kalorama Information report The Worldwide Market for Mobile Medical Apps details these products and presents a picture of the market today and what it may look like over […]December 1, 2010$2,800.00 – $5,990.00Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, […]December 1, 2010$995.00 – $3,000.00The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the introduction of vaccines in untapped disease markets and government’s acceptance and willingness to pay for new products. This has encouraged market participants to increase spending in research and development. This report, European Vaccine Markets, examines the […]November 1, 2010$1,995.00 – $3,990.00Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends The physician office laboratory (POL) is usually not broken out in market research reports covering the medical device and diagnostic industry. Numbers are often simply grouped in with hospital and service lab sales. But for marketing strategy, knowing where diagnostic tests occur is […]November 1, 2010
